Stockscreener 앱 받기
10.70
0.28%
0.03
전일 마감가:
$10.67
열려 있는:
$10.7
하루 거래량:
2,380
Relative Volume:
0.02
시가총액:
$206.60M
수익:
-
순이익/손실:
$6.21M
주가수익비율:
37.74
EPS:
0.2835
순현금흐름:
$-682.00K
1주 성능:
-0.19%
1개월 성능:
-0.47%
6개월 성능:
+2.00%
1년 성능:
+4.09%
1일 변동 폭
$10.70
$10.70
1주일 범위
$10.67
$10.73
52주 변동 폭
$10.29
$10.80
Translational Development Acquisition Corp Stock (TDAC) Company Profile
명칭
Translational Development Acquisition Corp
전화
(413) 204-2769
주소
52 E 83RD ST., NEW YORK
Compare TDAC vs LION, XXI, UMAC, CCXI, DMII
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TDAC
Translational Development Acquisition Corp
|
10.70 | 206.41M | 0 | 6.21M | -682.00K | 0.2835 |
LION
Lionsgate Studios Corp
|
14.62 | 4.45B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.445 | 1.72B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
22.48 | 1.07B | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
15.87 | 971.97M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.09 | 640.82M | 0 | 8.58M | -1.11M | 0.134 |
Translational Development Acquisition Corp Stock (TDAC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-09-21 | 개시 | Northland Capital | Outperform |
Translational Development Acquisition Corp 주식(TDAC)의 최신 뉴스
ProLogium (TDAC) on Bloomberg; Dunkirk ramp-up targeted Q2 2029 - Stock Titan
Price to earnings forward of Translational Development Acquisition Corp. – BOATS:TDACW - TradingView
TDACW (TDACW) Valuation: PE, PB & Fair Value Analysis - TradingKey
TDAC Shareholders Back SPAC Extension Amid ProLogium Deal - The Globe and Mail
TDAC Shareholders Back ProLogium Merger Extension, Retaining $156.8M in Trust and 85% Share Support - Minichart
Form 8K Translational Development Unit For: 23 June By Investing.com - Investing.com South Africa
TDAC reports 85% shareholder retention, $156.8M remaining in trust after extension vote - TradingView
Translational Development (TDAC) files redemption update on ProLogium deal (TDAC) - Stock Titan
TDAC (NYSE: TDAC) retains $156.8mm in trust as most holders stay - Stock Titan
ProLogium (TDAC) cites 2.4M cells delivered and Dunkirk gigafactory timeline - Stock Titan
MTNE Stock Price and Chart — NYSE:MTNE - TradingView
SPAC Defies Odds: Investor Bet on ProLogium’s Battery Tech Powers Merger - BriefGlance
TDAC retains $156.8 million in trust as 85% reject redemption By Investing.com - Investing.com Australia
TDAC Announces Successful Shr Redemption Results in Connection With Extension Vote - Moomoo
TDAC retains $156.8 million in trust as 85% reject redemption - Investing.com
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote - Barchart.com
ProLogium, Elysian MoU explores aviation batteries (TDAC) - Stock Titan
DYNC PE Ratio & Valuation, Is DYNC Overvalued - Intellectia AI
TDACTranslational Development Acquisition Corp Short Interest - Finviz
ProLogium to list on Nasdaq via TDAC merger at $3.8B valuation - MSN
Translational Development Acquisition shareholders approve extension for business combination By Investing.com - Investing.com Australia
Translational Development Acquisition shareholders approve extension for business combination - Investing.com UK
Translational Development Acquisition Wins Approval for SPAC Extension - TipRanks
TDAC (NASDAQ: TDAC) wins shareholder approval to extend SPAC deal deadline to 2027 - Stock Titan
ProLogium’s public listing is set to close in the second half of 2026 — valuing the only mass-production solid-state battery line on Earth at about $3.8 billion - MSN
Translational Development Acquisition Corp - TradingKey
Translational Development Acquisition Corp (TDACU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TDACW (TDACW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Translational Development Acquisition Corp (TDACU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Translational Development Acquisition Corp (TDACU) Institutional Confidence - TradingKey
Translational Development Acquisition Corp (TDACU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Translational Development Acquisition Corp (TDACU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Translational Development Acquisition Corp (TDACU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ProLogium, OPmobility partner on EV solid‑state modules (TDAC) - Stock Titan
AACP PE Ratio & Valuation, Is AACP Overvalued - Intellectia AI
AACP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Sponsor Converts Class B Shares to Class A - TipRanks
TDAC (NASDAQ: TDAC) converts 4.66M sponsor Class B shares into Class A stock - Stock Titan
TDACW Warrants Retreat 3.48%, Testing Key Support LevelsDemand Zone - newsline.com
TDACW Warrants Hold Steady at $1.55 as Trading Range TightensRounding Top - newsline.com
TDAC Maintains Tight Range as SPAC Holds Near Support LevelNew Listing Stocks - newsline.com
Translational Development Acquisition Corp. Warrants (TDACW) Surge 10.71% on Renewed Speculative InterestCommon Gap - newsline.com
ProLogium details tech, 800k cells shipped and TDAC tie‑up (TDAC) - Stock Titan
TDAC SEC FilingsTranslational Development Acquisition Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Linden Advisors/Linden GP disclose 950,000-share stake in TDAC (TDAC) - Stock Titan
Battery maker ProLogium to list on Nasdaq in $3.8 billion SPAC deal - MSN
Translational Development Acquisition Corp (TDAC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
0.38%
자본화:
|
볼륨(24시간):